Skip to Main Content

Author Details

Karen Chadwick
University Health Network, University of Toronto
1992
26
18
PMIDPaper TitleJournal TitlePublished Year
28751266Testosterone Responders to Continuous Androgen Deprivation Therapy Show Considerable Variations in Testosterone Levels on Followup: Implications for Clinical Practice.J Urol2018
28376164Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst2017
28458749What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?Can Urol Assoc J2017
28096933The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy.Can Urol Assoc J2016
25530379Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.Urology2015
23906628Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsies.Glycobiology2013
24343922Pharmacotherapy for personality disorder-prescribing practice at a high secure hospital: a preliminary report.Personal Ment Health2013
22871886Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response.Br J Cancer2012
21507190Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort.BJU Int2011
20219559Clinical significance of the positive surgical margin based upon location, grade, and stage.Urol Oncol2010
16796525Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure.AIDS Res Hum Retroviruses2006
15795302A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.J Virol2005
12754504Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.Nat Med2003
12663799Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.J Virol2003
12805437Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.J Virol2003
10749578A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.J Clin Invest2000
10933689Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.J Virol2000
11069234Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.J Infect Dis2000
10229227Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.Nat Med1999
10451505CD56 identifies monocytes and not natural killer cells in rhesus macaques.Cytometry1999
9360927Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.Science1997
9151834Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI.J Virol1997
9144289Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature1997
7489410In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.Nat Med1995
7587733Assessment of aerosol containment on the ELITE flow cytometer.Cytometry1995
1547669Comparison of lymphocyte immunophenotypes obtained simultaneously from two different data acquisition and analysis systems on the same flow cytometer.Cytometry1992
  • 1 - 26 of 26

Recommended Authors

Louise E Hogan
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 2
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 0
Vivek Naranbhai
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2006
Number of shared co-authors 1
Nadia R Roan
University of California, USA Gladstone Institutes san francisco
Career Start Year 2003
Number of shared co-authors 1
Timothy J Henrich
University of California san francisco
Career Start Year 2002
Number of shared co-authors 3
Sheila M Keating
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 3
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 2
Davey M Smith
University of California San Diego
Career Start Year 2001
Number of shared co-authors 4
Philip J Norris
Vitalant Research Institute
Career Start Year 2001
Number of shared co-authors 2
Alberto Bosque
George Washington University
Career Start Year 2000
Number of shared co-authors 3
Sudhir Penugonda
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 2
Maudi Killian
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 1
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 4
Janet Andersen
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 1
Steven G Deeks
University of California san francisco
Career Start Year 1988
Number of shared co-authors 5
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 3
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 2
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 0
Ann C Collier
University of Washington
Career Start Year 1984
Number of shared co-authors 3
Stephen Raffanti
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 3
Peter Bacchetti
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 3
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 1
Michael S Saag
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 2
Florin Vaida
School of Public Health, university of california san diego
Career Start Year 1980
Number of shared co-authors 3
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 2
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 3
Jeffrey D Lifson
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 3
Amalio Telenti
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 3
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 4

Collaborators

Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 16
Robert F Siliciano
Johns Hopkins University School of Medicine
Co-authored papers 12
Neil E Fleshner
University of Toronto
Co-authored papers 9
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 6
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 4
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 2
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 2
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 2
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 2
Robert G Bristow
University of Toronto
Co-authored papers 2
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 2
Joel E Gallant
Co-authored papers 2
Maciej Kwiatkowski
University of Basel, Academic Hospital Braunschweig
Co-authored papers 1
Marc K Hellerstein
University of California berkeley
Co-authored papers 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Tristan Juvet
Lions Gate Hospital
Co-authored papers 1
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 1
Michael A Liss
University of Texas Health San Antonio
Co-authored papers 1
Antoninus Soosaipillai
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Dharmendra Dingar
Montreal Heart Institute Montreal Quebec Canada.
Co-authored papers 1
Alan Dal Pra
University of Miami Miller School of Medicine
Co-authored papers 1
Douglas D Richman
Center for AIDS Research, University of California San Diego
Co-authored papers 1
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 1
Matt Friedlander
Ontario Institute for Cancer Research
Co-authored papers 1
Bruce D Walker
Ragon Institute of Mass General
Co-authored papers 1
Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 1
Hong Li
Qingdao Hospital of Traditional Chinese Medicine, Qingdao Haici Hospital
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Release 1.2